PAUL COOPER: Open Payments
NPI 1891853354 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 21 payments from 9 companies in 2025. Trend: 2023 $15 · 2024 $174 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $165 |
| PFIZER INC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
| SANOFI PASTEUR INC. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: JARDIANCE, MOUNJARO, AIRSUPRA, ELIQUIS, ZENPEP, Heplisav-B, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across OK — which companies pay providers there.
